Think Bioscience
PrivateLast Round
Series A
Jan 20, 2026
Est. Valuation
$140.18M
Total Funding Raised
$81.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Think Bioscience is a biotechnology company that develops small-molecule therapeutics for historically challenging drug targets using a proprietary synthetic biology platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Think Bioscience Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Think Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2026 | ||||
| Seed | May 7, 2024 | ||||
| Grant | Nov 25, 2022 | ||||
| Seed | Aug 18, 2022 | ||||
| Pre Seed | Sep 1, 2021 | ||||
Grant | Nov 19, 2020 |
Key People
Founding team and executive leadership
Think Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| Xora Innovation | Pre Seed, Seed |
| Wireframe Ventures | Pre Seed, Seed, Grant |
| Innovation Endeavors | Series A, Seed |
| CE-Ventures | Series A |
| Buff Gold Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
$55M round completed.
Think Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Think Bioscience's valuation, stock price, and market status.